M Ziemer, B Weidenthaler-Barth, P Gussek, M Pfeiffer… - Diagnostics, 2023 - mdpi.com
Selected patients with early-stage melanoma have a “hidden high risk” of poor oncologic
outcomes. They might benefit from clinical trials, and ultimately, if warranted by trial results …